Influx Healthtech came to market through an SME IPO that opened on 18 June 2025 and closed on 20 June 2025, and the shares listed on 25 June 2025 on NSE SME. The price band was ₹91 to ₹96 per share and one lot was 1200 shares, so the minimum application was ₹1,15,200. The issue size was ₹58.56 crore. It combined a fresh issue of new shares with an offer for sale by existing shareholders.
Maashitla Securities Private Limited was the registrar to the issue, and Rarever Financial Advisors Pvt. Ltd was the lead manager.
| Day |
|---|
| 1 |
| 2 |
| 3 |
Incorporated in September 2020, Influx Healthtech Limited is a healthcare-centric company dealing in contract manufacturing. The company is a trusted CDMO offering specialized services to clients in various industries. The company has three manufacturing plants in Thane, Maharashtra, each with an area of 9,676 square feet, 13,000 square feet, and 14,000 square feet, respectively. Product Portfolio:
Tablets, Capsules, and Powders Liquid Orals and Softgels Lozenges, Jellies, and Gummies Oral Dispersible Films (ODFs) Effervescent Tablets and Liquid-Fill Capsules Candies and Gym/Sports Supplements Skin Care and Body Care Products Hair Care and Beard Care Solutions Face Masks and Soaps. Ayurvedic / Herbal formulations Veterinary Feed Supplements Homecare solutions The Company assists Nutraceutical and Cosmetic companies with product development and manufacturing.
It provides end-to-end solutions, from development to production and regulatory affairs, allowing customers to concentrate on formulation and commercialization. As of June 11, 2025, there are 163 permanent employees on the payroll of the company.
As described in the offer document.
| Metric | 31-Mar-25 |
|---|
Mr. Munir Abdul Ganee Chandniwala, Mrs. Shirin Munir Ahmed Chandniwala, Mr. Abdul Ganee Abdul Rasul Chandniwala.. Promoter holding 99.85% before the issue and 73.53% after.
Work out the listing gain for this SME IPO
If the retail portion is not fully subscribed, every valid application is allotted in full. If it is oversubscribed, SEBI's rules require that as many applicants as possible receive at least one lot, so the shares are allotted by a computerised lottery across all valid applications, one lot each, until the retail portion is exhausted. Applying for more lots does not improve your chance in a lottery; it only increases what you receive if the issue is under-subscribed.
The basis of allotment document, published by the registrar on the allotment date, states the ratio: for example, one applicant in seven received one lot.
Allotment status is published by the registrar on its website, searchable by PAN, application number or demat account, and also on the exchange's website. Allotted shares are credited to the demat account the day before listing, and blocked money for unsuccessful applications is released the same day. The Rupix app can check allotment status by PAN once the registrar publishes it.
Shares list within three working days of the issue closing. On listing day the exchanges run a special pre-open session from nine o'clock, during which orders are collected and an opening price is discovered from them; trading in the share begins after that, usually around ten. The opening price is the listing price that appears on this page once the issue has listed, and the listing gain or loss is the difference between it and the issue price.
For a mainboard issue, the share then trades in the normal way with the exchange's price band for a new listing. For an SME issue, shares trade in lots rather than one at a time, and the market can be thin, so selling on listing day is not always possible at the opening price. Capital gains on shares sold within a year of allotment are short-term and taxed at the short-term rate.
Influx Healthtech IPO was a ₹58.56 crore book-built issue, comprising a fresh issue of ₹48 crore and an offer for sale of ₹10.56 crore. It was priced at ₹91–₹96 per share with a lot size of 1,200 shares (₹1,15,200). The IPO was open from June 18 to June 20, 2025. Shares listed on NSE SME on June 25, 2025 at ₹132.50, a 38.0% premium to the issue price of ₹96. Maashitla Securities Private Limited is the registrar.
Rarever Financial Advisors Pvt. Ltd. is the book running lead manager.
The price band of Influx Healthtech IPO is ₹91 to ₹96 per share.
The lot size of Influx Healthtech IPO is 1200 shares.
The minimum investment for Influx Healthtech IPO is approximately ₹1,15,200 based on the upper price band.
The allotment date of Influx Healthtech IPO is Jun 23, 2025.
Influx Healthtech IPO's final recorded GMP before listing was ₹20 per share (a 21% premium over the ₹96 upper price band). The shares listed at ₹132.5. GMP is unofficial and does not forecast or guarantee the actual listing price.
You can check Influx Healthtech IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Influx Healthtech IPO allotment status on Rupix for quick and easy access.
₹91 to ₹96 per share, against a face value of ₹10. Most applicants bid at the cut-off price, the top of the band, so that the application was valid whatever price the issuer finally fixed.
One lot was 1200 shares, and every application had to be a whole number of lots. At the top of the band that made the minimum application ₹1,15,200. After listing, SME shares also trade in lots rather than one share at a time.
₹1,15,200, for one lot of 1200 shares at the top of the price band. The amount was blocked in the applicant's bank account through ASBA or a UPI mandate while the issue was open, and released on the allotment date to applicants who were not allotted shares.
It opened on 18 June 2025 and closed on 20 June 2025.
The basis of allotment was published on 23 June 2025 by Maashitla Securities Private Limited, and allotted shares were credited to demat accounts before listing.
The shares listed on 25 June 2025 on NSE SME.
The issue size was ₹58.56 crore. The fresh issue was 50,00,400 shares (aggregating up to ₹48 crore). The offer for sale was 11,00,400 shares (aggregating up to ₹10.56 crore).